PLI New York Center
1177 Avenue of the Americas, (2nd floor)
New York, NY 10036.

Why you should attend
Over-the-counter (OTC) derivatives are key elements in many of our financial markets. The Dodd-Frank Act is substantially changing how these important instruments are regulated and transacted. This program will introduce you to both the instruments and their new environment.

A derivative is a financial instrument that allocates the risks and price exposures associated with a designated reference asset or entity between the parties thereto. Derivatives can provide price exposure or price insulation to changes in the price or level of an open-ended range of assets or baskets of assets, including indices, stocks, interest rates, currencies, bonds, commodities, insured risks, credit risks, investment funds, property, the weather and more. Derivatives are used in an infinite variety of ways by commercial, charitable, educational and governmental entities to manage the commercial and financial risks they confront. OTC derivatives have been bilaterally traded for many years. They are now becoming subject, in some cases, to required clearing and exchange-type trading. An understanding of the new regulations and of the characteristics, documentation and regulation of these instruments is the first step to effective lawyering.

At this program, the faculty will explain what OTC derivatives have been, what they are becoming and how they are documented. The faculty will also provide an overview of the new regulatory framework for OTC derivatives and OTC derivatives market participants and explain how the new regulatory framework is affecting these markets and market participants.

What you will learn

  • What are OTC derivatives?
  • What are the basic features of fixed income, credit, equity and commodity swaps?
  • How are derivatives commonly traded today?
  • What changes in trading methods are occurring?
  • What is the ISDA Master Agreement and how does it work?
  • What additional documentation has appeared in response to market changes?
  • How are OTC derivatives being regulated?

Mayer Brown partner Jerome J. Roche will be presenting on "Regulatory Fundamentals;" and Joshua D. Cohn – the chair of the program will be moderating the several panels as well as giving opening remarks.

For more information or to register, please click on the button below.